Christine O鈥橣arrelly, PhD; Hilary Watt, MSc; Daphne Babalis, PhD; et al.
open access
JAMA Pediatr. 2021;175(6):567-576. doi:10.1001/jamapediatrics.2020.6834
This randomized clinical trial tests the clinical effectiveness of a brief video feedback鈥揵ased parenting intervention in reducing behavior problems in children aged 12 to 36 months.
Judith S. Brand, PhD; Deborah A. Lawlor, PhD; Henrik Larsson, PhD; et al.
open access
JAMA Pediatr. 2021;175(6):577-585. doi:10.1001/jamapediatrics.2020.6856
This cohort study investigates associations of maternal hypertensive disorders of pregnancy with risks in offspring of autism spectrum disorders, attention-deficit/hyperactivity disorder, and intellectual disability, as well as variation in overall cognitive performance in offspring.
Burkhard Tönshoff, MD; Barbara Müller, PhD; Roland Elling, MD; et al.
open access
JAMA Pediatr. 2021;175(6):586-593. doi:10.1001/jamapediatrics.2021.0001
This cross-sectional investigation conducted in southwest Germany describes the rate of severe acute respiratory syndrome coronavirus 2 infections and the seroprevalence of antibodies in children aged 1 to 10 years, compared with a parent of each child, in a population-based sample.
Dustin D. Flannery, DO, MSCE; Sigrid Gouma, PhD; Miren B. Dhudasia, MBBS, MPH; et al.
free access
JAMA Pediatr. 2021;175(6):594-600. doi:10.1001/jamapediatrics.2021.0038
This cohort study assesses the association between maternal and neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)鈥搒pecific antibody concentrations.
Gunnar Toft, PhD, DMSc; Chuang Liu, PhD; Jyothi Menon, PhD; et al.
free access
JAMA Pediatr. 2021;175(6):601-608. doi:10.1001/jamapediatrics.2021.0124
This cross-sectional study uses data from national population-based registers to assess educational attainment and employment in young adulthood among individuals with and without a diagnosis of autism spectrum disorder before age 12 years in Denmark.
Aditi Vasan, MD; Chén C. Kenyon, MD, MSHP; Chris Feudtner, MD, PhD, MPH; et al.
free access
JAMA Pediatr. 2021;175(6):609-616. doi:10.1001/jamapediatrics.2020.6973
This economic evaluation uses data from the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) benefit summary to assess whether a transition from a paper voucher system to electronic benefits transfer cards is associated with greater participation in WIC.
Patrick DeMartino, MD; Meredith B. Haag, MD, MPH; Alyssa R. Hersh, MD, MPH; et al.
free access
JAMA Pediatr. 2021;175(6):617-623. doi:10.1001/jamapediatrics.2020.7140
This economic evaluation estimates the budget impact and affordability of a gene therapy for severe sickle cell disease from the perspective of US Medicaid programs with the highest prevalence of sickle cell disease while exploring the impact of an annuity payment model.
Viraraghavan Vadakkencherry Ramaswamy, MD, DM; Tapas Bandyopadhyay, MD, DM; Debasish Nanda, MD, DM; et al.
free access
online only
JAMA Pediatr. 2021;175(6):e206826. doi:10.1001/jamapediatrics.2020.6826
This systematic review and meta-analysis evaluates the risks and outcomes associated with 14 corticosteroid interventions administered to preterm infants.
Andres Roman-Urrestarazu, MD, PhD; Robin van Kessel, PhD; Carrie Allison, PhD; et al.
open access
online only
JAMA Pediatr. 2021;175(6):e210054. doi:10.1001/jamapediatrics.2021.0054
This national cohort study evaluates whether socioeconomic disadvantage is associated with autism spectrum disorder prevalence and the likelihood of accessing autism services in racial/ethnic minority groups and disadvantaged groups among school pupils in England.